Related Experiment Videos
Diffuse interstitial pulmonary disease during amiodarone treatment
Arzneimittel-Forschung
|January 1, 1984
Abstract:
A case of diffuse interstitial pneumopathy which was observed by photonic microscopy and confirmed by electron microscopy is presented in a patient treated with amiodarone only. The iatrogenic origin of this pneumopathy appears certain as clinical and radiological signs improved after amiodarone treatment was withdrawn.
Insights
A patient developed diffuse interstitial pneumopathy, a lung condition, solely from amiodarone treatment. Symptoms resolved after discontinuing this medication, confirming its iatrogenic cause.
Area of Science:
- Pulmonology
- Toxicology
- Pathology
Background:
- Amiodarone is a widely used antiarrhythmic drug.
- Drug-induced lung injury is a known but complex side effect.
- Diffuse interstitial pneumopathy presents a diagnostic challenge.
Observation:
- A case study of a patient treated exclusively with amiodarone.
- Microscopic examination (photonic and electron microscopy) revealed interstitial lung changes.
- Clinical and radiological signs were monitored throughout the treatment period.
Findings:
- The patient presented with diffuse interstitial pneumopathy.
- Histopathological findings confirmed the lung condition.
- Cessation of amiodarone treatment led to significant clinical and radiological improvement.
Implications:
- This case strongly suggests amiodarone as the causative agent for the observed pneumopathy.
- Highlights the importance of considering drug-induced lung disease in patients on amiodarone.
- Emphasizes the need for vigilant monitoring and prompt management of potential adverse effects.